VESIcare is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Solifenacin Succinate.
Product ID | 51248-151_07e04ccb-62f9-4096-a5c2-0f3f4245ddac |
NDC | 51248-151 |
Product Type | Human Prescription Drug |
Proprietary Name | VESIcare |
Generic Name | Solifenacin Succinate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2005-01-05 |
Marketing Category | NDA / NDA |
Application Number | NDA021518 |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | SOLIFENACIN SUCCINATE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2005-01-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021518 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-01-05 |
Marketing Category | NDA |
Application Number | NDA021518 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-01-05 |
Marketing Category | NDA |
Application Number | NDA021518 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-01-05 |
Ingredient | Strength |
---|---|
SOLIFENACIN SUCCINATE | 10 mg/1 |
SPL SET ID: | 9acee910-cdb2-4052-b8b3-c26aff1c8716 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
68151-5406 | VESIcare | VESIcare |
70518-1866 | VESIcare | VESIcare |
50090-0972 | VESIcare | VESIcare |
51248-150 | VESIcare | VESIcare |
51248-151 | VESIcare | VESIcare |
55154-3877 | VESIcare | VESIcare |
55154-3878 | VESIcare | VESIcare |
55154-3876 | VESIcare | VESIcare |
55154-3875 | VESIcare | VESIcare |
70518-2094 | VESIcare | VESIcare |
0093-5263 | Solifenacin Succinate | Solifenacin Succinate |
0093-5264 | Solifenacin Succinate | Solifenacin Succinate |
0591-3795 | Solifenacin succinate | solifenacin succinate |
0591-3796 | Solifenacin succinate | solifenacin succinate |
27241-037 | solifenacin succinate | solifenacin succinate |
27241-038 | solifenacin succinate | solifenacin succinate |
29300-328 | Solifenacin Succinate | Solifenacin Succinate |
29300-329 | Solifenacin Succinate | Solifenacin Succinate |
31722-027 | solifenacin succinate | solifenacin succinate |
31722-028 | solifenacin succinate | solifenacin succinate |
35561-286 | Solifenacin Succinate | solifenacin succinate |
42291-740 | Solifenacin Succinate | solifenacin succinate |
46708-192 | Solifenacin Succinate | Solifenacin Succinate |
46708-193 | Solifenacin Succinate | Solifenacin Succinate |
48792-7909 | solifenacin succinate | solifenacin succinate |
48792-7910 | solifenacin succinate | solifenacin succinate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VESICARE 88833757 not registered Live/Pending |
Astellas Pharma Inc. 2020-03-13 |
VESICARE 75932952 2535639 Live/Registered |
ASTELLAS PHARMA INC. 2000-03-02 |